African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Study on increasing the solubility and dissolution rate of sulfamethoxazole by cyclodextrins

Julide Sahin
  • Julide Sahin
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara Universcity, Ankara, 06100 TandoÄŸan-Ankara, Turkey.
  • Google Scholar
Nurten Ozdemir
  • Nurten Ozdemir
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Ankara Universcity, Ankara, 06100 TandoÄŸan-Ankara, Turkey.
  • Google Scholar


  •  Received: 31 January 2017
  •  Accepted: 27 March 2017
  •  Published: 22 August 2018

References

Bekers O, Uıjtendaal EV, Beıjnen JH, Bult A, Undrberg WJM (1991). Cyclodextrins in the pharmaceutical field. Drug Dev. Industrial Pharmacy17(11):1503-1549.
Crossref

 

Brewster ME, Loftsson T (2007). Cyclodextrins as pharmaceutical solubilizers. Advanced Drug Delivery Reviews 59:645-666.
Crossref

 

Connors KA, Mollica JA, (1966). Theoretical analysis of comparative studies of complex formation solubility, spectral and kinetic techniques. Journal of Pharmaceutical Sciences 55(8):772-780.
Crossref

 

Dhanaraju MD, Kumaran KS, Baskaran T, Moorthy MSR (1998). Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin. Drug Development and Industrial Pharmacy 24(6):583-587.
Crossref

 

Duchene D, Woussidjewe D (1990) The current state of β-cyclodextrin in pharmaceutics Acta pharmaceutica technologica 36(1):1-6.

 

Elgindy N, Elkhodainy K, Molokhia A, Elzoghby A (2011). Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation.Drug Development and Industrial Pharmacy 37(4):446-455.
Crossref

 

Fromming VK, Szejtli J (1994). Cyclodextrins in Pharmacy Dordrehcht, Kluwer Academic Publishers.
Crossref

 

Gabriel OKL, Yvonne TFT, Kok-Khiang P (2016). Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl-β-cyclodextrin.Asian Journal of Pharmaceutical Sciences11:536-546.
Crossref

 

Higuchi T, Connors KA (1965). Phase solubility techniques. Advances in Analytical Chemistry and Instrumentation 4:117-149.

 

Hirlekar RS, Sonawane SN, Kadam VJ (2009). Studies on the effect of water-soluble polymers on drug-cyclodextrin complex stability. American Association of Pharmaceutical Scientists 10(3):858-860.

 

Jambhekar SS, Breen P (2016). Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discovery Today 21(2):356-362.
Crossref

 

Loftsson T, Duchene D (2007). Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics 329:1-11.
Crossref

 

Loftsson T, Friðrıksdottır H, Olafsdottır BJ (1991). Solubilization and stabilization of drugs through cyclodextrin complexation. American Association of Pharmaceutical Scientists 3(4):215-217.

 

Loftsson T, Friðrıksdottır H, Thorısdottir S, Stefansson E (1994). The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. International Journal of Pharmaceutics 104:181-184.
Crossref

 

Loftsson T, Guðmundsdottir TK, Friðrıksdottır H (1996). The influence of water soluble polymers and pH on hydoxypropyl-β-cyclodextrin complexation of drugs. Drug Development and Industrial Pharmacy 22(5):401-405.
Crossref

 

Martindale (1993). the extra pharmacopoeia, 30th ed. Reynold J.E.F. ed. Pharmaceutical Press London, England P 208.

 

Özdemir N, Erkin J (2012). Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Development and Industrial Pharmacy 38(3):331-340.
Crossref

 

Patel SG, Rajput SJ (2009) Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes American Association of Pharmaceutical Scientists 10(2):660-669.

 

Polonisamy M, Khonam J (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile Drug Development and Industrial Pharmacy 37(4):373-386.
Crossref

 

Raja GV, Sekaran CB, Teja DW, Madhuri B, Jayasree B (2009). Simple spectrophotometric methods for the determination of sulfamethoxazole in pharmaceuticals using folinciocalteau and orcinol as reagents. Journal of Chemistry 6(2):357-360.

 

Sharma N, Baldi A (2016). Exploring versatile applications of cyclodextrins: an overview. Drug Delivery. 23(3):729-747.

 

Sinha VR, Anitha R, Ghosh S, Amita, Kumria R, Bhinge JR, Kumar M (2007). Physicochemical characterization and in vitro dissolution behaviour of celecoxib-β-cyclodextrin inclusion complexes. Acta Pharmaceutica 57:47-60.
Crossref

 

Szejtli J (1988). Cyclodextrin Technology, Dordrecht: Kluwer Academic Publishers.
Crossref

 

Szejtli J (1991a). Cyclodextrins in drug formulations: Part 1. Pharmaceutical Technology pp. 36-44.

 

The United States Pharmacopeia (USP XXII) (1990). United States Pharmacopeial Convention Inc. 1260, Twinbrook Parkway Rockwille, MD 20852.

 

Uekama K, Otagiri M (1987). Cyclodextrins in drug carrier systems. CRC 3(1):1-40.